Twenty-year trends in the prescription costs of Type 2 diabetes: Real world data and empirical analysis in Greece.

Aims: To estimate and compare the prescription costs for the management of patients with diabetes over a period of 20 years in Greece, based on real world data.

Methods: The records of outpatients with T2D, monitored at three diabetes centres, were examined in four cross-sections (1998, 2006, 2012, 2018). Prescribed medicines per patient, along with a set of clinical indicators were recorded.